Beth Harvey

University of Reading

Remote blood monitoring for cancer patients: A preliminary landscape analysis

Blood is the most utilized biological fluid for used for medical investigation, and therefore, providing new innovative blood testing and monitoring service models is imperative for improving healthcare.

In this presentation, Beth Harvey, University of Reading, outlines the opportunities and challenges for the adoption of remote blood testing and monitoring (RBTM) technologies as tools to increase operational efficiency, generate clinical value, and improve the quality of life of patients.

This video is an output from the Future Blood Testing Network. which is funded by EPSRC under Grant Number EP/W000652/1.



LIKE 1
Beth Harvey
Diagnostics Blood testing

Beth Harvey

Biography

University of Reading More

Beth Harvey

University of Reading

Beth Harvey is currently a researcher at the Henley Business School focusing on digital innovation in healthcare. Having completed her bachelor’s in biomedical science, Beth worked in the medical device and IVD regulatory sector with a consultancy firm in Vancouver before working with multiple UK manufacturers in the digital health space. She then went on to recieve the deans excellence award for her masters in digital health & data analytics where her dissertation focused on the opportunities and challenges for remote blood monitoring in oncology in collaboration with the Future Blood Network.